<?xml version="1.0" encoding="UTF-8"?>
<p>Malaria, the number one killer parasitic disease, is the worldâ€™s most significant protozoan disease. It has been reported by the World Health Organization that 228 million cases of malaria worldwide occurred in 2018. In addition, 
 <italic>Haemonchus contortus</italic> and 
 <italic>Trypanosoma brucei</italic> are some of the major causes of human morbidity and mortality in Africa and Some part of Asia. It has been noticed that 
 <italic>Terminalia</italic> sp. are one of the most important plant ingredient in traditional medicine to treat several infectious diseases such as malaria (
 <xref rid="B105" ref-type="bibr">Malterud, 2017</xref>). Of this, antiparasitic particularly antimalarial activities of 
 <italic>Terminalia</italic> sp. have been studied across the world. Also, the anticancer activity of 
 <italic>Terminalia</italic> sp. has been focused mainly since cancer is one of the most important human diseases that causes public health concerns worldwide. The diseases are abnormal cell growth with the potential to spread to other organs of the human body. Importantly, cancer is considered one of the major non-communicable diseases leading to high morbidity and mortality rates as well as a huge impact of economical loss on a large scale. In line with this report, the anticancer activity of 
 <italic>Terminalia</italic> sp. has then been a hotspot in search of novel anticancer therapy. Basing on the above insight into the importance of the 
 <italic>Terminalia</italic> sp., it is evident to compile a detailed report on the medicinal potential of the various species of 
 <italic>Terminalia</italic> sp. and its important phytoconstituents and pharmacological importance.
</p>
